N aive CD4
ϩ lymphocytes can differentiate into a variety of different effector cell types following activation by APCs (1) . Th1 cells are generally involved in cell-mediated immunity and secrete IL-2, IFN-␥, and lymphotoxin as their signature cytokines (2) . Th2 effector cells are generally associated with humoral immunity and the clearance of parasitic infections, and are identified by the secretion of IL-4, IL-5, IL-10, and IL-13 (3) . The factors that determine what type of effector cells develops during an immune response include Ag dose (4) , genetic makeup of the host (5) , and the APC involved (6) . However, the dominant factor appears to be the cytokine environment where the T cells develop (7) . IL-12 is the major inducer of Th1 differentiation. This cytokine is produced primarily by macrophages and dendritic cells (DC) 5 following exposure to stimuli such as bacterial products or CD40 ligation (2, 5, 8) . The biologically active form of this cytokine is a secreted 70-kDa heterodimer composed of a disulfidelinked p40 and p35 subunit, which are transcribed from separate genes (9) . The prototypical Th2-inducing cytokine is IL-4, which appears to be produced by activated CD4 ϩ cells themselves early in the immune response (7) .
We have recently shown that macrophages activated in the presence of immune complexes are different from classically activated macrophages (10) . Whereas classically activated macrophages produce high levels of IL-12 and low to moderate levels of IL-10, macrophages activated in the presence of immune complexes shut off IL-12 production (11) and induce IL-10 biosynthesis (12) . When these two types of differentially activated macrophages were used as APCs, they induced different CD4 ϩ T cell responses (13) . Classically activated macrophages induced the development of Th1 cells by virtue of their IL-12 secretion, whereas macrophages given immune complexes induced a Th2 response due to the absence of IL-12 and an increased production of IL-10. We have termed these latter macrophages type II-activated macrophages, due to their ability to promote Th2-type immune responses (14) .
DC are professional APCs specialized for Ag uptake, migration to secondary lymphoid organs, and Ag presentation to T cells. Indeed, DC are considered to be the most relevant APC in stimulating naive CD4
ϩ and CD8 ϩ lymphocytes in secondary lymphoid organs (15) . DC are capable of producing IL-12 following exposure to components of pathogens, including bacteria, viruses, and protozoa, or through CD40L by activated T cells (9) . IL-12 production by DC has been shown to induce Th1 immunity (16, 17) .
DC express Fc␥Rs, and these receptors have been shown to play an important role in the maturation of immature DC (18, 19) . They are also believed to play a role in the phenomenon of cross-presentation of Ags (20, 21) . Two of the Fc␥Rs, Fc␥RI and Fc␥RIII, associate with and signal through a common ␥ subunit, which contains an ITAM motif. Recently, other receptors on DC, such as DCAR, have been shown to also signal through the ␥-chain (22) .
In the present work, we measured IL-10 and IL-12 production by activated DC following Fc␥R ligation. We sought to determine whether immune complexes could influence the outcome of an adaptive immune response when DC were used as APCs. We show that DC shut off their production of IL-12p70 following Fc␥R ligation, and as a result induced a Th2-like T cell response. These results indicate that APCs that express Fc␥R on their surface can respond to immune complexes by reversing the Th1 biasing of innate immune stimuli.
Materials and Methods

Mice
Eight-week-old BALB/c and C57BL/6 mice were purchased from National Cancer Institute, Charles River Laboratories (Frederick, MD). Breeding pairs of DO11.10 mice transgenic for OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] (23) and TCR␣␤ were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice were maintained in HEPA-filtered caging units (Thoren Caging Systems, Hazleton, PA) at the University of Maryland (College Park, MD). Mice were used for experiments at 8 -10 wk of age.
Reagents
Bacterial oligodeoxynucleotides containing CpG motifs were a kind gift from R. Seder (Vaccine Research Center, National Institutes of Health, Bethesda, MD) and had the sequences TCAACGTTGA and GCTA GACGTTAGCGT (24) . OVA (grade VI) was purchased from Worthington Biochemical (Lakewood, NJ). In some cases, OVA was passed over a Detoxi-Gel column (Pierce, Rockford, IL) to remove trace LPS contamination. Rabbit IgG Ab to OVA (anti-OVA IgG) was purchased from Cappel (Durham, NC). IgG-OVA immune complexes were made by mixing a 10:1 molar excess of anti-OVA:OVA at room temperature for 30 min, as previously described (13) . LPS from Escherichia coli 0127:B8 was obtained from Sigma-Aldrich (St. Louis, MO).
Cells
Bone marrow-derived DC (BMDC) were prepared as described by Lutz et al. (25) , with minor modifications. Briefly, bone marrow was flushed from the femurs and tibias from mice and plated in 100-mm petri dishes at a concentration of 1 ϫ 10 6 cells/ml in RPMI 1640 supplemented with 10% FCS, penicillin/streptomycin, HEPES, glutamine, 50 M 2-ME, and 5 ng/ml recombinant murine GM-CSF (R&D Systems, Minneapolis, MN). On days 3 and 6, half the medium was removed and replaced with fresh medium. On day 9, nonadherent cells were removed and replated on 100-mm tissue-culture-treated dishes overnight to further remove adherent cells. Nonadherent cells were removed from dishes and used for experiments. By flow cytometry, cells were generally 80% CD11c ϩ pure and had a CD11c ϩ CD11b ϩ CD8␣ Ϫ phenotype, with only moderate expression of MHC class II. For in vitro maturation of DC, TNF-␣ (R&D Systems) was added to day-7 cultures at a concentration of 20 ng/ml. Cells remained in culture for 36 h for maturation before use in experiments. These cells were determined to be mature by analyzing expression of MHC class II, CD40, and CD86 by flow cytometry.
Splenic DC (SPDC) were prepared by digestion of spleens using liberase (Roche, Indianapolis, IN) at a concentration of 0.2 U/ml at 37°C for 30 min. Cells were then passed through a strainer to remove tissue debris and washed by centrifugation. To isolate DC, positive selection using antiCD11c ϩ microbeads (Miltenyi Biotec, Auburn, CA) were used according to manufacturer's instructions. By flow cytometry, cells were generally 75-80% CD11c ϩ and had the phenotype CD11c ϩ CD8␣ ϩ/Ϫ MHC class II high . Bone marrow-derived macrophages (BMM) were prepared as described previously (11) . Briefly, bone marrow was flushed from the femurs and tibias from mice, and cells were plated in petri dishes in DMEM supplemented with 10% FCS, penicillin/streptomycin, glutamine, and 20% conditioned medium from the supernatant of M-CSF-secreting L929 fibroblasts. Media was replaced on day 6, and cells were used at 10 -12 days for experiments. CD4 ϩ T cells were prepared from the spleens of DO11.10 mice by immunomagnetic positive selection using anti-CD4 (L3T4) microbeads (Miltenyi Biotec) as previously described (13) . Cells were Ͼ95% CD4 ϩ CD45RB high as determined by flow cytometry.
Cell stimulation assays
For stimulation of macrophages, 2 ϫ 10 5 macrophages were plated per well in a 48-well plate in RPMI 1640 and primed for 12 h with 100 U/ml recombinant murine IFN-␥ (R&D Systems). Cells were then washed, and activated with 5 g/ml CpG DNA and either 150 g/ml OVA or 140 g/ml OVA plus 10 g/ml IgG-OVA. For stimulation of DC, 2 ϫ 10 5 cells/well were added to 48-well plates containing 5 g/ml CpG and either 150 g/ml OVA or 150 g/ml OVA plus IgG-OVA. For T cell stimulation assays, 5 ϫ 10 5 CD4 ϩ T cells were added 2 h later. One week following primary stimulation, CD4 ϩ cells were harvested, washed, and restimulated with 5 ϫ 10 5 splenocytes. Cytokines were analyzed 24 h after secondary stimulation. For intracellular staining, CD4 ϩ cells were secondarily activated with PMA/ionomycin for 4 h followed by intracellular staining. Some T cells were stimulated in the presence of 500 pg/ml rIL-12 (R&D Systems). In some cases, CD40L-expressing L929 fibroblasts were used in place of CD4 ϩ T cells for CD40 signaling. For this, 1 ϫ 10 5 fibroblasts were adhered to plates the night before.
Cytokine production
Cytokines were measured by ELISA using the following Ab pairs from BD Pharmingen (San Jose, CA): IL-12p70, 9A5 and C17.8; IL-12p40, C15.6 and C17.8; IL-10, JES5-2A5 and JES5-16E3; IFN-␥, R4-6A2 and XMG1.2; and IL-4, 11B11 and BVD6-24G2. For intracellular staining, brefeldin A was added 1 h following PMA/ionomycin addition. Cells were then fixed and permeabilized 3 h later using Cytofix/Cytoperm kit from BD Pharmingen. Following staining, cells were analyzed by a BD FACSCalibur flow cytometer (BD Pharmingen).
Cytokine mRNA was measured by real-time PCR. BMDC and BMM were stimulated on day 8 with LPS (10 ng/ml) Ϯ erythrocytes opsonized with IgG for 5 h. Cells were harvested and washed by centrifugation, and then lysed in TRIzol (Invitrogen Life Technologies, Carlsbad, CA). RNA was extracted following the manufacturer's protocol and stored at Ϫ80°C. Real-time PCR was conducted using the ABI PRISM 7700 Sequence Detection System and SYBR Green core PCR reagents (Applied Biosystems, Foster City, CA). Murine IL-12p35 primer sequences used were sense, 5Ј-CCGCGTCGTGAC CATCA; and anti-sense, 5Ј-CAGAGGGCCTTGAGCCTTTC; and p40 sequences were sense, 5Ј-ACATGTACCGAA-GTCCAATGCA; and antisense, 5Ј-GGAACACATGCCCACTTGCT. 
DC transfer experiments
BMDC were resuspended in complete medium at a concentration of 8 ϫ 10 6 cells/ml. One group of DC received 100 g/ml OVA alone. The second group received the same amount of OVA plus 10 ng/ml LPS and 5 g/ml CpG oligonucleotides. The third group received LPS/CpG and a total of 100 g/ml OVA, of which 7 g/ml was IgG-OVA. Medium was added to bring the final cell concentration to 4 ϫ 10 6 cells/ml, and stimulated DC were incubated in vitro for 8 h. Individual BALB/c mice were immunized i.p. with a total of 2 ϫ 10 6 stimulated DC and 50 g OVA in a volume of 500 l. No adjuvants were administered. This vaccination with OVA and stimulated DC was repeated on day 12. Serum was collected 7 days following the second vaccination and the titers of total OVA-specific IgG, IgG1, and IgG2a were determined as previously described (13) . Briefly, OVA-coated plates were incubated with increasing dilutions of serum, and then exposed to alkaline phosphatase conjugated goat anti-mouse Ig (HϩL), IgG1, and IgG2a (Southern Biotechnology Associates, Birmingham, AL). Titers were determined as the final dilution with an OD at 405 nm over 0.1 U.
Results
Cytokine production by CpG-stimulated DC DC were generated from murine bone marrow precursors (BMDC), and stimulated in vitro with CpG oligonucleotides and Ag (OVA). Stimulation resulted in the production of IL-12p70 (Fig. 1A, f) and IL-12p40 (Fig. 1B ) from these cells. Activated BMDC made minimal IL-10 in response to CpG stimulation (Fig.  1C ). BMM were stimulated in parallel (Fig. 1, right) . When stimulated with OVA and CpG oligonucleotides, macrophages produced high levels of IL-12p70 (Fig 1A) , IL-12p40 (Fig 1B) , and they secreted moderate levels IL-10 ( Fig. 1C) . Both BMDC and BMM were also stimulated in the presence of IgG-opsonized OVA (Fig. 1, Ⅺ) . DC activated in the presence of immune complexes produced almost no detectable IL-12p70 (Fig. 1A) . However, immune complexes did not reduce IL-12p40 biosynthesis by DC, nor did they affect the low amounts of IL-10 produced by DC (Fig. 1C) . In macrophages, the synthesis of all three of these molecules was affected by the presence of immune complexes. Both IL-12p70 and IL-12p40 were dramatically reduced following activation in the presence of immune complexes (Fig. 1, A and B) and IL-10 biosynthesis was increased (Fig. 1C) , as previously reported by us using different stimuli (13, 26) . Thus, both DC and macrophage respond to immune complexes by altering their production of IL-12p70.
The alteration of cytokine production by DC in response to immune complexes was independent of the type of stimulation condition. Both unprimed and IFN-␥-primed DC, stimulated with either CpG (Fig. 2, Ⅺ) or LPS (f), responded to immune complexes by down-regulating IL-12p70.
T cell biasing by immune complexes
To determine the effect that APC cytokine production had on T cell activation, differentially activated macrophages or DC were used as APCs for naive DO11.10 CD4 ϩ T cells. We previously demonstrated that activated macrophages induced T cells to produce primarily IFN-␥ in response to Ag (13) . This observation is confirmed in Fig. 3A . Macrophages receiving CpG and OVA Ag induced T cells to produce relatively high levels of IFN-␥ and little IL-4 in the secondary response (Fig. 3A, bottom) . In contrast, macrophages receiving IgG immune complexes (IgG-OVA) induced the production of higher levels of IL-4 and reduced amounts of IFN-␥ from T cells. This deviation in T cell cytokine production also occurred when DC were used as APCs (Fig. 3A, top) . DC that were activated in the presence of IgG immune complexes gave rise to T cells that produced primarily IL-4, whereas DC that were activated in the presence of OVA Ag alone gave rise to T cells that secreted significantly more IFN-␥ than IL-4 (Fig. 3A) .
Intracellular staining of the CD4 ϩ cells was performed to determine the proportions of T cells making IFN-␥ or IL-4 (Fig. 3B) . Cytokine production by activated DC. BMDC were either primed overnight with IFN-␥ (100 U/ml) or not, and then stimulated (S) with either 5 g/ml CpG oligonucleotides (Ⅺ, left axis) or 100 ng/ml LPS (f, right axis) in the presence or absence of IgG-OVA immune complexes (ϩ IgG). Cytokines were measured 20 h later by ELISA.
FIGURE 3. Measurement of CD4
ϩ T cell cytokine production following stimulation by BMDC or BMM. A, CD4 ϩ T cells from DO11.10 mice were added to BMDC (top) or BMM (bottom) that had been stimulated with CpG oligonucleotides in the presence of OVA alone (Ⅺ) or OVA plus IgG-OVA (^). One week later, T cells were washed and given a secondary stimulation under nonbiasing conditions, using T-depleted splenocytes and OVA. Secondary cytokine production was measured by ELISA 24 h following secondary stimulation. B, For intracellular staining, CD4 ϩ cells were stimulated as above and then restimulated in vitro with PMA/ionomycin for an additional 5 h. Cells were fixed and permeabilized and stained with mAbs to IFN-␥ (abscissa) and IL-4 (ordinate). Results are from a single experiment that is representative of at least three. ‫,ء‬ Significant difference (p Ͻ 0.01) between OVA and IgG-OVA groups.
In agreement with the ELISA data, 41% of CD4 ϩ cells activated by BMDC receiving CpG and OVA produced IFN-␥, whereas and only 1% produced IL-4. However, BMDC that were given CpG and IgG-OVA reversed this profile. Only 5% of the CD4 ϩ cells produced IFN-␥, whereas 21% produced IL-4. Thus, BMDC respond to immune complexes by altering their own cytokine production, which influences T cell cytokine responses.
To determine the contribution of DC-derived IL-12 to T cell biasing, similar studies were performed with DC activated in the presence of immune complexes and rIL-12. As shown above, the addition of immune complexes to activated DC induced a Th2-type biasing of naive T cells (Fig. 4) . However, the simultaneous addition of rIL-12 to these cells at the time of activation reversed this biasing and restored Th1-like responses. Thus, IL-12 is a major contributor to Th1 biasing by activated DC, and the abrogation of IL-12 biosynthesis by immune complexes reverses this biasing.
FIGURE 4. Measurement of CD4
ϩ T cell cytokine production following stimulation by BMDC. CD4 ϩ T cells from DO11.10 mice were added to BMDC that had been stimulated with CpG oligonucleotides in the presence of OVA alone (Ⅺ) or OVA plus IgG-OVA (^). A parallel population of T cells were stimulated with DC receiving OVA plus IgG-OVA, along with 500 pg rIL-12 (f). Cytokine production was measured by ELISA 4 days following the primary stimulation. 
DC maturation and T cell biasing
To correlate DC responses with Fc␥R expression, we performed similar types of experiments, using two populations of DC-lacking Fc␥R. Primary SPDC were allowed to spontaneously mature in culture, as previously described (27) . The mature phenotype of these cells was confirmed by flow cytometry, showing an increase in surface CD40 and CD86 expression on these cells relative to immature BMDC (Fig. 5) . Importantly, this maturation process resulted in a marked decrease in the surface Fc␥R expression on these cells (Fig. 5, bottom) . Similar to the studies described above, these mature SPDC were activated in the presence or absence of immune complexes, and then used as APCs. Activated SPDC secreted IL-12p70 (Fig. 6A) and IL-12p40 (Fig. 6B ), but little detectable IL-10 (Fig. 6C) . These SPDC failed to respond to immune complexes by altering their cytokine production. They did not decrease their production of either subunit of IL-12, nor did they increase IL-10 production when activated in the presence of immune complexes (Fig. 6) . As a result, activated SPDC induced the production of IFN-␥ from T cells, and this biasing was not reversed when these cells were exposed to immune complexes (Fig.   7) . Similar studies were performed with BMDC that were matured in culture by the addition of exogenous TNF, 36 h before stimulation. By flow cytometry, these in vitro-matured DC exhibited all the activation characteristics of mature SPDC, including low Fc␥R expression (data not shown). Similar to SPDC, these cells failed to respond to immune complexes by altering their cytokine production (Fig. 8) , and they failed to reverse T cell biasing (Fig. 8, inset) . Thus, DC decrease their expression of Fc␥R upon maturation, and as a result, fail to bias T cell responses when activated in the presence of immune complexes.
BMDC differ from macrophages in their regulation of IL-12
We examined the mechanism of down-regulation of IL-12p70 by macrophages and immature DC following their exposure to immune complexes. Real-time PCR (Fig. 9 ) was performed to measure IL-12p40 and IL-12p35 mRNA levels in parallel populations of BMDC and macrophages following stimulation in the presence (Ⅺ) or absence (f) of immune complexes. Unlike macrophages, which down-regulated both IL-12p40 and IL-12p35 in response to immune complexes (Fig. 9) , BMDC show no decrease in IL-12p40 following Fc␥R ligation. However, they did exhibit a dramatic decrease in IL-12p35 (Fig. 9) . Thus, although both macrophages and DC shut off IL-12p70 production following Fc␥R ligation, they do so by different mechanisms.
In vivo biasing at the level of the APC
Vaccination studies using BMDC that were activated in vitro in the presence or absence of immune complexes were performed to determine the extent that DC could influence Ab production to a nominal Ag. DC were stimulated in vitro in the presence of OVA Ag, and then both DC plus Ag were injected into mice. No adjuvants other than the activated DC were added. The total amount of OVA-specific IgG and the isotype of OVA-specific IgG was measured following a second boost with Ag and stimulated DC. The administration of OVA Ag plus resting DC induced a minimal immune response (Fig. 10) , presumably due to the lack of innate activation by the LPS-free OVA that was used in these studies. Vaccination with OVA plus CpG/LPS-activated DC induced a better IgG response, which resulted in the production of moderate levels of IgG1 and a modest amount of IgG2a (Fig. 10) . However, DC activated in the presence of immune complexes produced a significantly higher level of total OVA-specific IgG, and the majority of this increase was due to a dramatic increase in the level of IgG1 (Fig. 10) . Thus, DC exposed to immune complexes at the time of activation can preferentially induce an increased humoral immune response to Ag, resulting in higher IgG1 production.
Discussion
In this work, we show that innate activation of DC results in the production of IL-12 by these cells. This observation confirms previous reports of others (28) . We extend these observations to show that DC activation in the presence of immune complexes has a profound effect on IL-12 biosynthesis. Exposure of DC to immune complexes causes a dramatic decrease in the production of biologically active IL-12p70 (Fig. 1) . The extent of this decrease is comparable to what we had previously observed in activated macrophages (13) . We also show that the alterations in DC cytokine production following their exposure to immune complexes can have a direct result on T cell biasing. The IL-12 that is produced by activated BMDC causes these cells to induce a Th1-like T cell response predominated by IFN-␥. However, the presence of immune complexes turns off IL-12 synthesis and results in a reversal of the Th1 biasing that was caused by TLR activation. In the presence of immune complexes, DC induce Th2-like responses from naive T cells. These T cells make relatively low levels of IFN-␥ and higher amounts of IL-4.
As a control for these studies, we used two populations of mature DC, which we show express low levels of Fc␥R. Primary DC were obtained from the spleens of naive mice. These cells spontaneously mature in culture (27) , probably as a result of the isolation procedure. Immature BMDC, which were allowed to mature in culture in the presence of exogenous TNF, were also used. Both populations of DC express high levels of costimulatory molecules, but low levels of Fc␥R. Consequently, these cells failed to respond to immune complexes. These cells neither altered their cytokine production nor did they reverse Th1 biasing in response to immune complexes.
We previously demonstrated that immune complexes could change cytokine production from activated macrophages (13) .
Those previous studies were likely to be relevant to certain immunopathological conditions, where activated macrophages are found in lesions surrounded by T cells (29, 30) . They may also pertain to the presentation of complex Ags, such as bacteria, by macrophages, where the bacteria themselves can provide the activating stimulus for macrophage cytokine production. In both of these cases, stimulated macrophages represent a relevant APC, whose physiology could be changed by the presence of immune complexes. The present studies extend these observations to DC, a population of cells more likely to present Ag to naive T cells. We show that these cells can also respond to pre-existing IgG-containing immune complexes, provided that they express sufficiently high levels of Fc␥R.
At first glance, BMDC resemble macrophages with regard to their ability to respond to immune complexes and alter their cytokine production. However, on closer examination there were several important differences between activated macrophages and BMDC. First, DC made only minimal amounts of IL-10, and these levels were not increased in response to immune complexes. This is clearly different from macrophages, which produce prodigious amounts of IL-10 in response to Fc␥R ligation (12) . Second, although both populations of cells decreased the production of IL12p70 in response to immune complexes, BMDC did not diminish the transcription of p40. Rather, they regulate IL-12 production exclusively at the level of the p35 subunit.
The alteration of cytokine production by APCs in response to immune complexes that we observe may contribute in an unexpected way to the elevated production of Ab that is produced in a secondary immune response. Although it is well appreciated that the expansion and differentiation of memory B and T cells represents the major reasons for the efficiency of the secondary immune response, the present studies suggest that APC alterations may also contribute to this process. Fundamental differences in cytokine production by macrophages and DC, caused by the presence of IgG immune complexes, may result in a cytokine environment that preferentially induces T cells to promote B cell development and differentiation. Further studies to elucidate the extent that APCs can influence or modify host immune responses during immunity and immunopathogenesis are warranted. FIGURE 10. Ab production following vaccination with stimulated DC and OVA. BMDC from BALB/c mice were incubated in vitro with OVA alone, LPS/CpG plus OVA, or with LPS/CpG, and IgG-OVA for 8 h, as described in Materials and Methods. A total of 2 ϫ 10 6 BMDC along with 50 g of OVA were transferred i.p. into BALB/c mice in the absence of adjuvant. This procedure was repeated on day 12. Seven days after the second treatment, blood was collected, and OVA-specific IgG (HϩL), IgG1, and IgG2a titers were measured by ELISA. The titer is defined as the final dilution of serum where the average absorbance at 405 nm equaled or exceeded 0.1 OD units. At least three values were averaged in each group.
